Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

NASDAQ:LYRA

Overview | Financials
Company Name Lyra Therapeutics, Inc.
Symbol LYRA
Currency USD
Price 0.175
Market Cap 11,455,098
Dividend Yield 0%
52-week-range 0.163 - 6.79
Industry Biotechnology
Sector Healthcare
CEO Dr. Maria Palasis Ph.D.
Website https://lyratherapeutics.com

An error occurred while fetching data.

About Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with

Related Stocks

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

31.05 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

13.07 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

3.57 USD

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

37.82 USD

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

0.55 USD

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

2.28 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

1.52 USD

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

1.12 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.916 USD

Financials

Numbers are in millions USD

Numbers are in millions USD